Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05345613 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tranexamic Acid During Colonic Endoscopic Resection Procedures

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 13, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 1, 2025 to Sep 1, 2026
    • Study completion date: Oct 1, 2025 to Oct 1, 2026
    v6
  2. Primary completion date: Apr 1, 2025 to Sep 1, 2025v5
  3. Primary completion date: Apr 1, 2024 to Apr 1, 2025
    • Study completion date: Oct 1, 2024 to Oct 1, 2025
    v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Colonoscopy with polypectomy reduces the incidence and mortality associated with colon cancer. However, polypectomy is associated with adverse events such as bleeding. Tranexamic acid (TXA) is a synthetic derivative of lysine that exerts antifibrinolytic effects and may prevent bleeding. The investigators aim to evaluate the effect of local TXA on preventing intraprocedural and postprocedural bleeding in patients undergoing endoscopic mucosal resection (EMR) of large colon polyps.
Trial Details
NCT Number NCT05345613
Lead Sponsor Assaf-Harofeh Medical Center
Conditions
(from sponsor)		 Colon Neoplasm
Related terms Colonic Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov